It's Time to Flip the Script on Blood Testing

<p>In this episode of Let's Talk Medtech, Babson Diagnostics CEO David Stein&nbsp;discusses the company's progress toward commercialization. Babson has developed a model for diagnostic blood testing that&nbsp;maintains a high standard of accuracy, yet requires only one-tenth the sample size of traditional venipuncture methods. Babson&nbsp;also uses a&nbsp;proprietary blood collection device to collect the sample at a participating&nbsp;pharmacy, then the sample is processed back at Babson's labs.</p>